Growth Plan

For 2023, Inter Scientific announces the comprehensive expansion of its analytical and regulatory services, offering a full turn-key service for its clients. This is a major milestone for Inter Scientific on their mission to be a world leader in nicotine & cannabinoid science and sees the company expanding its laboratories into a 10,000sq foot facility.

The expansion is supported by the European Regional Development Fund and is part of the Northern Powerhouse and will create up to 40 new jobs in the area over the course of the plan.

“We are delighted to announce our growth plans which will allow us to further support our clients whilst providing careers in the local area. We are excited to expand our services and expertise into the areas critical for our clients’ success”

David Lawson, Founder at Inter Scientific

An expansion of capabilities

Inter Scientific's new facility will house new toxicological services including in-silico and in-vitro toxicology, in addition to creating a dedicated nicotine product laboratory and cannabinoid product laboratory. It will also provide for extractable and leachable analysis for pharmaceutical and nicotine product analysis.

Offering innovative solutions

About Inter Scientific

With over a decade of experience in regulatory affairs and analytical testing, Inter Scientific offer innovative solutions to ensure that products are compliant with regulations, directives, and standards. The company has built a strong bedrock of knowledge and expertise, as well as substantial analytical capabilities.

Inter Scientific values quality, which is why we proudly hold a variety of accreditations and certifications, including ISO 9001, ISO 14001, ISO 27001, ISO 17025 and Good Manufacturing Practice (GMP) as part of their Environmental and Quality Management System (EQMS).